Loading provider…
Loading provider…
Nuclear Medicine Physician in Saint Louis, MO
NPI: 1063506392Primary Practice Location
BARNES JEWISH HOSPITAL
1 Barnes Jewish Hospital Plz, Saint Louis, MO
Primary Employer
Washington University School of Medicine
surgery.wustl.edu
HQ Phone
Get MD Farrokh's Phone Numberphone_androidMobile
Get MD Farrokh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMO State Medical License
MO State Medical License
1988 - 2026
WI State Medical License
1988 - 1989

American Board of Nuclear Medicine
Nuclear Medicine
Shiraz University of Medical Sciences
Medical School
Until 1977
Medical College Of Wisconsin
mcw.edu
Residency • Nuclear Medicine
1986 - 1988
Washington University/B-JH/SLCH Consortium
Residency • Nuclear Medicine
1988 - 1990
Residency • Radiology-Diagnostic
—
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 78815Nuclear medicine study with CT imaging skull base to mid-thigh | 246 | 249 |
| 2 | 77080Bone density measurement using dedicated X-ray machine | 95 | 95 |
| 3 | 78306Bone and/or joint imaging, whole body | 41 | 43 |
| 4 | 78195Imaging of lymphatic tissue and lymph node | 14 | 14 |
| 5 | 78816Nuclear medicine study with CT imaging whole body | 14 | 14 |
Advances in Positron Emission Tomographic Imaging of Lung Cancer
Authors: Delphine Chen
Publication Date: 2005-01
Authors: Barry Siegel, Boone Goodgame
Journal: J Thorac Oncol
Authors: Barry Siegel, Jeffrey Olsen
Journal: Int J Radiat Oncol Biol Phys
Publication Date: 2010-10-01
Lead Sponsor: Washington University School of Medicine
Collaborators: Celgene Corporation
Intervention / Treatment: BIOLOGICAL: Cetuximab, DRUG: Cisplatin, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: nab-Paclitaxel
Lead Sponsor: ImaginAb, Inc.
Intervention / Treatment: DRUG: ⁸⁹Zr-Df-IAB22M2C
Lead Sponsor: Washington University School of Medicine
Collaborators: AbbVie
Intervention / Treatment: DRUG: 18F-FluorApoTrace